MARINUS PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a549e8ab-cc87-4f5a-9c47-e62e661e9f14/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-131.5M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002479 |
| FY 2022 | $-112.8M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003305 |
| FY 2021 | $-96.9M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004279 |
| FY 2020 | $-67.9M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002646 |
| FY 2019 | $-54.4M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002792 |
| FY 2018 | $-37.2M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001860 |
| FY 2017 | $-19.0M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001587 |
| FY 2016 | $-28.2M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001650 |
| FY 2015 | $-24.4M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-003873 |
| FY 2014 | $-11.9M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-019211 |
| FY 2013 | $-5.4M | 2013-01-01 – 2013-12-31 | evidence 0001104659-15-019211 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MARINUS PHARMACEUTICALS, INC. — all facts · Revenue · Net Income